Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMLIMEA)

Drug Name

Varespladib methyl Drug Info

Synonyms

A-002; LY-333013; S-3013; Varespladib methyl (oral formulation, coronary artery disease); PLA2 inhibitors (inflammation), Lilly/Shionogi; Varespladib (oral formulation, coronary artery disease), Anthera; Varespladib methyl (oral formulation, coronary artery disease), Anthera

Indication

Disease Entry	ICD 11	Status	REF
Rheumatoid arthritis	FA20	Phase 3	[1]

Cross-matching ID

PubChem CID: 9886917
CAS Number: CAS 172733-08-3
TTD Drug ID: DMLIMEA

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Secretory phospholipase A2 (sPLA2)	TT2XHSJ	NOUNIPROTAC	Modulator	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01130246) VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome. U.S. National Institutes of Health.
2	Varespladib. Am J Cardiovasc Drugs. 2011;11(2):137-43.